On 28 October 2014
Ranbaxy Laboratories will hold a meeting of the Board of Directors of the Company on 28 October 2014, to consider and approve Standalone and Consolidated Unaudited Financial Results for the second quarter and half year ending 30 September 2014 (Q2).Powered by Capital Market - Live News